These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24952669)

  • 1. XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells.
    Moreno-Martínez D; Nomdedeu M; Lara-Castillo MC; Etxabe A; Pratcorona M; Tesi N; Díaz-Beyá M; Rozman M; Montserrat E; Urbano-Ispizua A; Esteve J; Risueño RM
    Oncotarget; 2014 Jun; 5(12):4337-46. PubMed ID: 24952669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined inhibition of XIAP and autophagy induces apoptosis and differentiation in acute myeloid leukaemia.
    Huang Z; Zhou J; Jiang Y; Han Y; Wang X; Li F; Jiang S; Yu K; Zhang S
    J Cell Mol Med; 2023 Jun; 27(12):1682-1696. PubMed ID: 37154878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism and functional role of XIAP and Mcl-1 down-regulation in flavopiridol/vorinostat antileukemic interactions.
    Rosato RR; Almenara JA; Kolla SS; Maggio SC; Coe S; Giménez MS; Dent P; Grant S
    Mol Cancer Ther; 2007 Feb; 6(2):692-702. PubMed ID: 17308065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis.
    Tamm I; Richter S; Scholz F; Schmelz K; Oltersdorf D; Karawajew L; Schoch C; Haferlach T; Ludwig WD; Wuchter C
    Hematol J; 2004; 5(6):489-95. PubMed ID: 15570290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery.
    Zhou J; Lu X; Tan TZ; Chng WJ
    Mol Oncol; 2018 Jan; 12(1):33-47. PubMed ID: 29063676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML.
    Carter BZ; Mak DH; Schober WD; Koller E; Pinilla C; Vassilev LT; Reed JC; Andreeff M
    Blood; 2010 Jan; 115(2):306-14. PubMed ID: 19897582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of X-linked inhibitor of apoptosis protein (XIAP) is an independent unfavorable prognostic factor in childhood de novo acute myeloid leukemia.
    Sung KW; Choi J; Hwang YK; Lee SJ; Kim HJ; Kim JY; Cho EJ; Yoo KH; Koo HH
    J Korean Med Sci; 2009 Aug; 24(4):605-13. PubMed ID: 19654940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells.
    Carter BZ; Gronda M; Wang Z; Welsh K; Pinilla C; Andreeff M; Schober WD; Nefzi A; Pond GR; Mawji IA; Houghten RA; Ostresh J; Brandwein J; Minden MD; Schuh AC; Wells RA; Messner H; Chun K; Reed JC; Schimmer AD
    Blood; 2005 May; 105(10):4043-50. PubMed ID: 15687241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase-independent cell death in AML: caspase inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis.
    Carter BZ; Kornblau SM; Tsao T; Wang RY; Schober WD; Milella M; Sung HG; Reed JC; Andreeff M
    Blood; 2003 Dec; 102(12):4179-86. PubMed ID: 12920030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells.
    Cornet-Masana JM; Moreno-Martínez D; Lara-Castillo MC; Nomdedeu M; Etxabe A; Tesi N; Pratcorona M; Esteve J; Risueño RM
    Oncotarget; 2016 Apr; 7(17):23239-50. PubMed ID: 26992240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircPAN3 mediates drug resistance in acute myeloid leukemia through the miR-153-5p/miR-183-5p-XIAP axis.
    Shang J; Chen WM; Wang ZH; Wei TN; Chen ZZ; Wu WB
    Exp Hematol; 2019 Feb; 70():42-54.e3. PubMed ID: 30395908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells.
    Gil-Kulik P; Dudzińska E; Radzikowska-Büchner E; Wawer J; Jojczuk M; Nogalski A; Wawer GA; Feldo M; Kocki W; Cioch M; Bogucka-Kocka A; Rahnama M; Kocki J
    BMC Cancer; 2020 May; 20(1):435. PubMed ID: 32423430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of serotonin receptor type 1 in acute myeloid leukemia impairs leukemia stem cell functionality: a promising novel therapeutic target.
    Etxabe A; Lara-Castillo MC; Cornet-Masana JM; Banús-Mulet A; Nomdedeu M; Torrente MA; Pratcorona M; Díaz-Beyá M; Esteve J; Risueño RM
    Leukemia; 2017 Nov; 31(11):2288-2302. PubMed ID: 28193998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.
    Tamm I; Richter S; Oltersdorf D; Creutzig U; Harbott J; Scholz F; Karawajew L; Ludwig WD; Wuchter C
    Clin Cancer Res; 2004 Jun; 10(11):3737-44. PubMed ID: 15173080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5.
    Carter BZ; Mak DH; Schober WD; Dietrich MF; Pinilla C; Vassilev LT; Reed JC; Andreeff M
    Blood; 2008 Apr; 111(7):3742-50. PubMed ID: 18187663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.
    Porwit-MacDonald A; Ivory K; Wilkinson S; Wheatley K; Wong L; Janossy G
    Leukemia; 1995 Jul; 9(7):1191-8. PubMed ID: 7543174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
    Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
    Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of survivin and X-linked inhibitor of apoptosis protein (XIAP) genes in acute myeloid leukemia (AML).
    Ibrahim AM; Mansour IM; Wilson MM; Mokhtar DA; Helal AM; Al Wakeel HM
    Lab Hematol; 2012 Mar; 18(1):1-10. PubMed ID: 22459568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embelin sensitizes acute myeloid leukemia cells to TRAIL through XIAP inhibition and NF-κB inactivation.
    Yang T; Lan J; Huang Q; Chen X; Sun X; Liu X; Yang P; Jin T; Wang S; Mou X
    Cell Biochem Biophys; 2015 Jan; 71(1):291-7. PubMed ID: 25358405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blasts.
    Dembitz V; Lalic H; Kodvanj I; Tomic B; Batinic J; Dubravcic K; Batinic D; Bedalov A; Visnjic D
    BMC Cancer; 2020 Nov; 20(1):1090. PubMed ID: 33176741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.